Bioqube Ventures - aVenture Asset Manager Research
Location
City of Brussels, Flemish Brabant, BE
Founded
2015
Bioqube Ventures is a specialist life sciences venture capital fund focused on investing in innovative European biotech companies. The firm leverages its venture creation experience to translate and de-risk scientific innovation, aiming to maximize value for investors. Bioqube Ventures typically invests in early-stage companies through its independent fund, Bioqube Factory Fund I, targeting Series A, B, and C rounds.
Notable portfolio companies include Bicara Therapeutics, which has raised $273 million, and Primmune Therapeutics, with $4 million raised. The firm is led by key partners with deep expertise in the biotech sector, although specific names are not provided. Bioqube Ventures offers unique value-add services such as strategic guidance and operational support to help portfolio companies advance their scientific innovations.
Bioqube Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Bioqube Ventures is a life sciences venture capital fund, investing in innovative European biotech firms and translating scientific innovation into value for investors.
Series B 60%Series A 20%Series C 20%
Concentration shown as share of disclosed investments by stage.